Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA DISHMAN PHARMA SANOFI INDIA/
DISHMAN PHARMA
 
P/E (TTM) x 29.3 30.0 97.8% View Chart
P/BV x 14.6 3.3 435.4% View Chart
Dividend Yield % 7.4 0.7 1,117.2%  

Financials

 SANOFI INDIA   DISHMAN PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
DISHMAN PHARMA
Mar-16
SANOFI INDIA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs7,939374 2,120.4%   
Low Rs5,454129 4,231.3%   
Sales per share (Unadj.) Rs1,202.8197.0 610.6%  
Earnings per share (Unadj.) Rs269.521.2 1,271.7%  
Cash flow per share (Unadj.) Rs287.734.7 828.9%  
Dividends per share (Unadj.) Rs570.002.00 28,500.0%  
Avg Dividend yield %8.50.8 1,071.0%  
Book value per share (Unadj.) Rs527.0179.9 293.0%  
Shares outstanding (eoy) m23.0380.70 28.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.61.3 435.9%   
Avg P/E ratio x24.911.9 209.3%  
P/CF ratio (eoy) x23.37.3 321.0%  
Price / Book Value ratio x12.71.4 908.4%  
Dividend payout %211.59.4 2,241.2%   
Avg Mkt Cap Rs m154,22420,307 759.4%   
No. of employees `000NANA-   
Total wages/salary Rs m4,0595,355 75.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,70115,898 174.2%  
Other income Rs m730265 275.1%   
Total revenues Rs m28,43116,163 175.9%   
Gross profit Rs m8,3494,103 203.5%  
Depreciation Rs m4191,091 38.4%   
Interest Rs m17944 1.8%   
Profit before tax Rs m8,6432,334 370.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,437624 390.8%   
Profit after tax Rs m6,2061,710 362.9%  
Gross profit margin %30.125.8 116.8%  
Effective tax rate %28.226.7 105.5%   
Net profit margin %22.410.8 208.3%  
BALANCE SHEET DATA
Current assets Rs m36,12111,018 327.8%   
Current liabilities Rs m27,4259,517 288.2%   
Net working cap to sales %31.49.4 332.5%  
Current ratio x1.31.2 113.8%  
Inventory Days Days11757 204.7%  
Debtors Days Days173 486.4%  
Net fixed assets Rs m12,14818,787 64.7%   
Share capital Rs m230161 142.5%   
"Free" reserves Rs m11,90614,354 82.9%   
Net worth Rs m12,13614,516 83.6%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m48,27929,805 162.0%  
Interest coverage x509.43.5 14,676.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.60.5 107.6%   
Return on assets %12.98.9 144.7%  
Return on equity %51.111.8 434.1%  
Return on capital %71.417.5 407.2%  
Exports to sales %14.124.9 56.6%   
Imports to sales %14.63.7 389.8%   
Exports (fob) Rs m3,9043,956 98.7%   
Imports (cif) Rs m4,037594 679.2%   
Fx inflow Rs m3,9044,952 78.8%   
Fx outflow Rs m4,037697 579.4%   
Net fx Rs m-1334,255 -3.1%   
CASH FLOW
From Operations Rs m3,9872,786 143.1%  
From Investments Rs m6,509-1,529 -425.7%  
From Financial Activity Rs m-15,827-941 1,681.9%  
Net Cashflow Rs m-5,331317 -1,684.4%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 27.1 23.0 118.3%  
FIIs % 6.3 12.0 52.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 38.6 102.6%  
Shareholders   62,870 52,291 120.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Sanofi India vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs Dishman Pharma Share Price Performance

Period Sanofi India Dishman Pharma S&P BSE HEALTHCARE
1-Day -1.68% 2.87% -1.03%
1-Month -16.36% -2.45% -5.08%
1-Year 34.36% 96.38% 57.36%
3-Year CAGR -0.44% 89.34% 18.12%
5-Year CAGR 6.44% 38.20% 18.86%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 570.0 per share. This amounted to a Dividend Payout ratio of 211.5%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.